Biocon Shares Down As Firm Withdraws EU Approval Of Two Drugs
Business
European drug regulators informed Biocon that the manufacturing facilities for two drugs needed to be re-inspected.
Previous post
Amazon Adds 'Instant Pickup' In US Brick-And-Mortar Push
Next post
JK Paper#39;s AGM on September 14, 2017
Comments